AAIC 2025 Abstract
Lecanemab in DIAD: 6‐Month Amyloid PET Results from the DIAN‐TU‐001 Trial
Trial in peopleInterventions
Papers by Pratik R. Bhagunde
2 results
- AAIC 2025 Abstract
Lecanemab Subcutaneous Formulation for Maintenance Dosing in Early Alzheimer’s Disease (AD)
Computational studyInterventions